These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22735029)

  • 1. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.
    Di Vinci A; Brigati C; Casciano I; Banelli B; Borzì L; Forlani A; Ravetti GL; Allemanni G; Melloni I; Zona G; Spaziante R; Merlo DF; Romani M
    Transl Res; 2012 Nov; 160(5):355-62. PubMed ID: 22735029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
    Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA
    Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.
    Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T
    Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations associated with progression and recurrence in meningiomas.
    Pérez-Magán E; Campos-Martín Y; Mur P; Fiaño C; Ribalta T; García JF; Rey JA; Rodríguez de Lope A; Mollejo M; Meléndez B
    J Neuropathol Exp Neurol; 2012 Oct; 71(10):882-93. PubMed ID: 22964784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
    Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
    Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
    Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
    Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methylation and expression analysis of p16(INK4a) and RB genes in meningiomas].
    Chen MN; Mao Q; Liu YH; Mao BY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):277-9. PubMed ID: 15192837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation markers of malignant potential in meningiomas.
    Vengoechea J; Sloan AE; Chen Y; Guan X; Ostrom QT; Kerstetter A; Capella D; Cohen ML; Wolinsky Y; Devine K; Selman W; Barnett GH; Warnick RE; McPherson C; Chiocca EA; Elder JB; Barnholtz-Sloan JS
    J Neurosurg; 2013 Oct; 119(4):899-906. PubMed ID: 23930849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
    Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
    Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A
    J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas.
    Tabernero MD; Espinosa AB; Maillo A; Rebelo O; Vera JF; Sayagues JM; Merino M; Diaz P; Sousa P; Orfao A
    Oncologist; 2007 Oct; 12(10):1225-36. PubMed ID: 17962616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
    Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
    Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
    Monleón D; Morales JM; Gonzalez-Segura A; Gonzalez-Darder JM; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
    Cancer Res; 2010 Nov; 70(21):8426-34. PubMed ID: 20861191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade.
    Majchrzak-Celińska A; Paluszczak J; Szalata M; Barciszewska AM; Nowak S; Baer-Dubowska W
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1593-601. PubMed ID: 25648363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in the malignant transformation of meningiomas.
    Gao F; Shi L; Russin J; Zeng L; Chang X; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Mack WJ; Wang K
    PLoS One; 2013; 8(1):e54114. PubMed ID: 23349797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
    Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
    J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.